121 related articles for article (PubMed ID: 7749215)
21. [Significance and reversal of MDR1/P-gp in pancreatic cancer chemotherapy].
Guo JC; Zhao YP; Liao Q; Zhu Y
Zhonghua Wai Ke Za Zhi; 2007 Nov; 45(21):1488-90. PubMed ID: 18275717
[TBL] [Abstract][Full Text] [Related]
22. Potential role for human P-glycoprotein in the transport of lacosamide.
Zhang C; Chanteux H; Zuo Z; Kwan P; Baum L
Epilepsia; 2013 Jul; 54(7):1154-60. PubMed ID: 23551115
[TBL] [Abstract][Full Text] [Related]
23. Binding of an optically pure photoaffinity analogue of verapamil, LU-49888, to P-glycoprotein from multidrug-resistant human leukemic cell lines.
Qian XD; Beck WT
Cancer Res; 1990 Feb; 50(4):1132-7. PubMed ID: 1967551
[TBL] [Abstract][Full Text] [Related]
24. Iodination increases the activity of verapamil derivatives in reversing PGP multidrug resistance.
Barattin R; Gerby B; Bourges K; Hardy G; Olivares J; Boutonnat J; Arnoult C; D'Hardemare AD; Ronot X
Anticancer Res; 2010 Jul; 30(7):2553-9. PubMed ID: 20682982
[TBL] [Abstract][Full Text] [Related]
25. Multidrug resistance in leukemic cell line K562/A02 induced by doxorubicin.
Yang CZ; Luan FJ; Xiong DS; Liu BR; Xu YF; Gu KS
Zhongguo Yao Li Xue Bao; 1995 Jul; 16(4):333-7. PubMed ID: 7668104
[TBL] [Abstract][Full Text] [Related]
26. Downregulation of JNK/SAPK activity is associated with the cross-resistance to P-glycoprotein-unrelated drugs in multidrug-resistant FM3A/M cells overexpressing P-glycoprotein.
Kang CD; Ahn BK; Jeong CS; Kim KW; Lee HJ; Yoo SD; Chung BS; Kim SH
Exp Cell Res; 2000 Apr; 256(1):300-7. PubMed ID: 10739677
[TBL] [Abstract][Full Text] [Related]
27. Reversal of multidrug resistance by methoxypolyethylene glycol-block-polycaprolactone diblock copolymers through the inhibition of P-glycoprotein function.
Elamanchili P; McEachern C; Burt H
J Pharm Sci; 2009 Mar; 98(3):945-58. PubMed ID: 18623213
[TBL] [Abstract][Full Text] [Related]
28. Effect of combination of suboptimal concentrations of P-glycoprotein blockers on the proliferation of MDR1 gene expressing cells.
Hwang M; Ahn CH; Pine PS; Yin JJ; Hrycyna CA; Licht T; Aszalos A
Int J Cancer; 1996 Jan; 65(3):389-97. PubMed ID: 8575863
[TBL] [Abstract][Full Text] [Related]
29. Reversal of drug sensitivity in MDR subline of P388 leukemia by gene-targeted antisense oligonucleotide.
Nakashima E; Matsushita R; Negishi H; Nomura M; Harada S; Yamamoto H; Miyamoto K; Ichimura F
J Pharm Sci; 1995 Oct; 84(10):1205-9. PubMed ID: 8801335
[TBL] [Abstract][Full Text] [Related]
30. Calcium antagonists potentiate P-glycoprotein-independent anticancer drugs in chronic lymphocytic leukemia cells in vitro.
Vilpo J; Koski T; Vilpo L
Haematologica; 2000 Aug; 85(8):806-13. PubMed ID: 10942926
[TBL] [Abstract][Full Text] [Related]
31. Reversal of multidrug resistance in mouse lymphoma cells by phenothiazines.
Molnar J; Molnar A; Mucsi I; Pinter O; Nagy B; Varga A; Motohashi N
In Vivo; 2003; 17(2):145-9. PubMed ID: 12792975
[TBL] [Abstract][Full Text] [Related]
32. Effects of P-glycoprotein expression on cyclic AMP and volume-activated ion fluxes and conductances in HT-29 colon adenocarcinoma cells.
Kunzelmann K; Slotki IN; Klein P; Koslowsky T; Ausiello DA; Greger R; Cabantchik ZI
J Cell Physiol; 1994 Dec; 161(3):393-406. PubMed ID: 7962123
[TBL] [Abstract][Full Text] [Related]
33. Differential interactions of Pgp inhibitor thaliblastine with adriamycin, etoposide, taxol and anthrapyrazole CI941 in sensitive and multidrug-resistant human MCF-7 breast cancer cells.
Chen G; Teicher BA; Frei E
Anticancer Res; 1996; 16(6B):3499-505. PubMed ID: 9042212
[TBL] [Abstract][Full Text] [Related]
34. Modulation of doxorubicin resistance in P388/ADR cells by Ro44-5912, a tiapamil derivative.
De Jong G; Gelmon K; Bally M; Goldie J; Mayer L
Anticancer Res; 1995; 15(3):911-6. PubMed ID: 7645981
[TBL] [Abstract][Full Text] [Related]
35. The effects of anticancer drugs in combination with nimodipine and verapamil on cultured cells of glioblastoma multiforme.
Durmaz R; Deliorman S; Uyar R; Işiksoy S; Erol K; Tel E
Clin Neurol Neurosurg; 1999 Dec; 101(4):238-44. PubMed ID: 10622452
[TBL] [Abstract][Full Text] [Related]
36. MDR-1 gene expression is a minor factor in determining the multidrug resistance phenotype of MCF7/ADR and KB-V1 cells.
Kim HM; Oh GT; Hong DH; Kim MS; Kang JS; Park SM; Han SB
FEBS Lett; 1997 Jul; 412(1):201-6. PubMed ID: 9257720
[TBL] [Abstract][Full Text] [Related]
37. Reversal of P-gp mediated multidrug resistance in-vitro and in-vivo by FG020318.
Chen LM; Liang YJ; Ruan JW; Ding Y; Wang XW; Shi Z; Gu LQ; Yang XP; Fu LW
J Pharm Pharmacol; 2004 Aug; 56(8):1061-6. PubMed ID: 15285852
[TBL] [Abstract][Full Text] [Related]
38. Lentivirus-mediated RNA interference reversing the drug-resistance in MDR1 single-factor resistant cell line K562/MDR1.
Ye X; Liu T; Gong Y; Zheng B; Meng W; Leng Y
Leuk Res; 2009 Aug; 33(8):1114-9. PubMed ID: 19036441
[TBL] [Abstract][Full Text] [Related]
39. Effects of a novel photoactivated photosensitizer on MDR1 over-expressing human breast cancer cells.
Chen JJ; Liu SP; Zhao J; Wang SC; Liu TJ; Li X
J Photochem Photobiol B; 2017 Jun; 171():67-74. PubMed ID: 28478351
[TBL] [Abstract][Full Text] [Related]
40. Effects of 12 Ca2+ antagonists on multidrug resistance, MDR1-mediated transport and MDR1 mRNA expression.
Takara K; Sakaeda T; Tanigawara Y; Nishiguchi K; Ohmoto N; Horinouchi M; Komada F; Ohnishi N; Yokoyama T; Okumura K
Eur J Pharm Sci; 2002 Aug; 16(3):159-65. PubMed ID: 12128170
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]